Moomoo AI 已提取核心信息
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.
与T2 Biosystems, Inc. [TTOO] 相关的约翰·斯佩尔泽尔三世于2024年2月24日执行了一项交易，涉及收购67股普通股。该交易被归类为'M'，表示行使或转换衍生证券。在这笔交易之后，斯珀泽尔在T2 Biosystems的直接持股总量已达到400股。公告中未披露交易价格和股票总价值。
与T2 Biosystems, Inc. [TTOO] 相关的约翰·斯佩尔泽尔三世于2024年2月24日执行了一项交易，涉及收购67股普通股。该交易被归类为'M'，表示行使或转换衍生证券。在这笔交易之后，斯珀泽尔在T2 Biosystems的直接持股总量已达到400股。公告中未披露交易价格和股票总价值。
有用
没用
